Tag: #lifesciences

From oncology research to drug discovery to point of care, the unified analysis of various forms of omics data is helping researchers and clinicians generate new insights and offer more personalized care. While the value of multi-omics is apparent, our healthcare and life sciences customers want better tools to get started, build applications, and scale up […]

Blog is guest authored by Don Freed and Brendan Gallagher from Sentieon. To help customers easily build, deploy, and scale workloads, Amazon Omics now supports pre-built Ready2Run workflows from third-party software companies and open-source pipelines. Read more about the launch here. Since 2014, AWS Partner Sentieon has been focused on developing highly-optimized algorithms for bioinformatics […]

Blog is guest authored by Maxim Mass, Rosi Bajari, and Bryan Lajoie from Element Biosciences. To help customers easily build, deploy, and scale workloads, Amazon Omics now supports pre-built Ready2Run workflows from third-party software companies and open-source pipelines. Read more about the launch here. Last year, Element Biosciences launched the AVITI benchtop sequencing instrument to […]

Blog is guest authored by Harry Clifford from NVIDIA. To help customers easily build, deploy, and scale workloads, Amazon Omics now supports pre-built Ready2Run workflows from third-party software companies and open-source pipelines. Read more about the launch here. As the cost of sequencing a human genome continues to decrease, the volume of sequencing data is […]

The AWS Life Sciences Team is excited about the upcoming Bio-IT World Conference and Expo 2023 in Boston from May 16-18. The symposium unites a community of life sciences and technology experts from around the world, and is the world’s premier event showcasing the technologies and analytic approaches that solve problems, accelerate science, and drive […]

Blog is guest authored by Guy Vinograd, Co-founder and Chief Technology Officer at BioT. With a vision to make world-class medical care accessible to patients wherever they are, Israeli startup BioT provides a platform for building cloud-powered medical devices. Its innovative technology helps connect Internet of Things (IoT) medical devices to the cloud. This allows […]

Data is at the heart of any modern pharmaceutical company throughout every stage of the value chain. Understandably, data is also central to industry regulations and continues to be one of the main topics during FDA inspections. However, questions still arise around how to meet data integrity requirements when operating in the cloud. Regulatory requirements […]

In recent years, cloud technology has been embraced as an enabler of value creation, helping improve enterprise resilience, innovation speed and scalability without the need for large capital expenditures and even reducing ongoing operational costs. Fortune 500 pharma and MedTech companies could gain by 2030, $10-15 billion in improved EBITDA run rates and $25-30 billion […]

Like businesses in any other industry, pharmaceutical companies compete with each other. Despite their individual races to the finish line, the mission is the same: develop and produce lifesaving and life-changing treatments that move medicine, and humanity, forward. The recognition of this mutual goal, and the potential of breaking down siloes to share information, has […]

re:Invent is an opportunity to dive into innovative technologies and explore new ideas, and for healthcare and life sciences (HCLS) organizations, it is the time to think about how to reinvent collaborations, improve data driven decision making, and drive new discoveries, all with the goal of improving patient outcomes. At re:Invent 2022, we continued our […]